Dr. Eric A. Secemsky and Dr. S. Jay Mathews share their perspectives on the current state of IVUS, the barriers to broader adoption, and what’s needed to ensure more patients benefit from better imaging and informed decision-making.
Listen to the experts discuss how IVUS is being applied in real-world practice and why it’s becoming an essential component of peripheral vascular intervention.
Dr. Eric A. Secemsky, Dr. Paul Gagne, and Dr. Mahmood Razavi discuss how better imaging leads to better decision-making and opens the door to improved patient outcomes.
Funding to accelerate development of next-generation intravascular ultrasound platform and support FDA clearance for U.S. market launch San Jose, CA – March 25, 2025 – Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence, today announced the successful closing of its Series B financing with new […]
Dr. Eric A. Secemsky and Dr. Peter Schneider discuss why IVUS is becoming essential, not only in PAD interventions, but also in dynamic aortic dissections where real-time visualization is critical to patient safety and procedural success.
San Jose, CA – January 7, 2025 – Evident Vascular Inc., a medical technology startup backed by Vensana Capital® developing an AI-powered next-generation intravascular ultrasound (IVUS) platform, is pleased to announce the appointment of Scott R. Ward to its Board of Directors. With over 40 years of leadership in healthcare and medical technology, Mr. Ward […]
MedTech Strategist | Mary Stuart
Intravascular ultrasound has been proven to make endovascular interventions safer, and good outcomes more durable, but only a minority of clinicians use it.
Scientific Advisory Board includes clinical experts in interventional cardiology, interventional radiology and vascular surgery. Bruce Shook, seasoned medtech executive and entrepreneur, joins Board of Directors.
